In one paragraphArticle in Irish journal of medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
18 authors.
Sezin AydemirCerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, Istanbul, 34098, Türkiye.ORCID http://orcid.org/0000-0002-5876-2601 Necmiye Keser OzturkFaculty of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Immune Deficiency Research and Application Center, Marmara University Hospital, Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, The Isil Berat Barlan Center for Translational Medicine, Istanbul, Türkiye.ORCID http://orcid.org/0000-0003-2623-8626 Betul Gemici KaraaslanCerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, Istanbul, 34098, Türkiye.ORCID http://orcid.org/0000-0002-0303-7146 Zeynep MericCerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, Istanbul, 34098, Türkiye.ORCID http://orcid.org/0000-0003-1792-1570 Sevgi Bilgic EltanFaculty of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Immune Deficiency Research and Application Center, Marmara University Hospital, Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, The Isil Berat Barlan Center for Translational Medicine, Istanbul, Türkiye.ORCID http://orcid.org/0000-0003-0561-3343 Haluk Cezmi CokuğrasCerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, Istanbul, 34098, Türkiye.ORCID http://orcid.org/0000-0002-0086-3936 Elif Karakoç AydınerFaculty of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Immune Deficiency Research and Application Center, Marmara University Hospital, Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, The Isil Berat Barlan Center for Translational Medicine, Istanbul, Türkiye.ORCID http://orcid.org/0000-0003-4150-5200 Safa BarisFaculty of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Immune Deficiency Research and Application Center, Marmara University Hospital, Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, The Isil Berat Barlan Center for Translational Medicine, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-4730-9422 Ahmet OzenFaculty of Medicine, Department of Pediatrics, Division of Allergy and Immunology, Immune Deficiency Research and Application Center, Marmara University Hospital, Istanbul Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiencies, The Isil Berat Barlan Center for Translational Medicine, Istanbul, Türkiye.ORCID http://orcid.org/0000-0002-9065-1901 Esra YucelCerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, Istanbul, 34098, Türkiye.ORCID http://orcid.org/0000-0003-3712-2522 Ayca KiykimCerrahpasa Faculty of Medicine, Department of Pediatric Allergy and Immunology, Istanbul University-Cerrahpasa, Kocamustafapasa, Fatih, Istanbul, 34098, Türkiye. ayca.kiykim@iuc.edu.tr.ORCID http://orcid.org/0000-0001-5821-3963 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
introductionHematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood.
methodsChildren aged 8-18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children's Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls.
resultsThirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments.
conclusionDespite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.
Indexed as
AnxietyChildrenHematopoietic stem cell transplantationInborn errors of immunityQuality of life
What OpenQuestion holds
Textmetadata
Read underepoch 390